Research is key to future treatment
The BRC is a partnership between The Royal Marsden and The Institute of Cancer Research, London. It supports innovative translational research, taking leading-edge cancer research from the laboratory and rapidly translating it into a clinical setting.
What does the future hold for Melanoma & Urological cancers?
Join us on Tuesday 2 July for an evening of the latest clinical research innovations and what this means for patient care and treatment
Find out moreLatest updates
What does the future hold for prostate cancer?
In March 2019, over 180 people attended our patient open evening to find out more about the latest clinical innovations in prostate cancer research and the impact that this has for care and treatment.
Find out more